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Abstract
Background: Recognition of microorganisms by the innate immune system is mediated by pattern recognition receptors,
including Toll-like receptors and cytoplasmic RIG-I-like receptors. Chlamydia, which include several human pathogenic
species, are obligate intracellular gram-negative bacteria that replicate in cytoplasmic vacuoles. The infection triggers a host
response contributing to both bacterial clearance and tissue damage. For instance, type I interferons (IFN)s have been
demonstrated to exacerbate the course of Chlamydial lung infections in mice.
Methods/Principal Findings: Here we show that Chlamydia pneumoniae induces expression of IFN-stimulated genes (ISG)s
dependent on recognition by nucleotide-sensing Toll-like receptors and RIG-I-like receptors, localized in endosomes and the
cytoplasm, respectively. The ISG response was induced with a delayed kinetics, compared to virus infections, and was
dependent on bacterial replication and the bacterial type III secretion system (T3SS).
Conclusions/Significance: Activation of the IFN response during C. pneumoniae infection is mediated by intracellular
nucleotide-sensing PRRs, which operate through a mechanism dependent on the bacterial T3SS. Strategies to inhibit the
chlamydial T3SS may be used to limit the detrimental effects of the type I IFN system in the host response to Chlamydia
infection.
Citation: Chiliveru S, Birkelund S, Paludan SR (2010) Induction of Interferon-Stimulated Genes by Chlamydia pneumoniae in Fibroblasts Is Mediated by
Intracellular Nucleotide-Sensing Receptors. PLoS ONE 5(4): e10005. doi:10.1371/journal.pone.0010005
Editor: Stefan Bereswill, Charite ´-Universita ¨tsmedizin Berlin, Germany
Received March 8, 2010; Accepted March 15, 2010; Published April 6, 2010
Copyright:  2010 Chiliveru et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by The Danish Medical Research Council Grant nos. 271-05-0488 and 09-072636, the Lundbeck Foundation (Grants no. R17-
A1526 and R19-A2023), the Kathrine og Vigo Skovgards Fond, the Aase and Ejnar Danielsens Fond, and The Aarhus University Research Foundation. The funders
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: srp@microbiology.au.dk
Introduction
Chlamydia are gram negative obligate intracellular bacteria and
among the smallest bacteria known [1,2]. Chlamydia pnuemoniae
causes respiratory tract infections like pneumonia, pharyngitis, and
sinusitis. All chlamydial species share a unique biphasic develop-
mental cycle in which the chlamydiae alternate between two
morphologically distinct forms. The elementary body (EB) is the
infectious but metabolically inert form whereas the reticulate body
(RB) is the non-infectious but metabolically active form [3].
Sensing of microbial infections via specific innate immune
receptors plays a pivotal role in the proper functioning of the host
innate immune system. The germline-encoded recognition
receptors (PRR)s act as a molecular switch triggering the innate
immune activation and in turn tightly regulate the downstream
immune responses to microbial infections [4]. The microbial
structures recognized by PRRs are termed pathogen-associated
molecular patterns (PAMP)s, and include lipid-rich structures (e.g.
lipopolysaccharide) and nucleotides (e.g. RNA). Two important
classes of PRRs are the membrane-bound Toll-like receptors
(TLR)s, which are localized in the plasma membrane and
endosomal compartments, and the Retinoid acid induced gene
(RIG)-I-like receptors (RLR)s, which are localized in the cytoplasm
[5]. While TLRs recognize a wide range of different structures, the
RLRs uniquely recognize RNAs [5].
Intracellular pathogens propagate inside host cells due to
dependence on cellular factors for completion of the life cycle.
In addition to viruses, certain bacteria and protozoa reside inside
cells. Chlamydia replicates in cytoplasmic vacuoles in the host cells
[2,3], which triggers an inflammatory host response, contributing
to both clearing of the infection and tissue damage [6]. Both in
vitro and in vivo studies on C. pneumoniae revealed the predominant
role of TLR2 over TLR4 following infection [7]. Recent studies
reported that in addition to the TLR pathway yet another
recognition system involving the cytoplasmic PRRs NOD1 and
NOD2 is vital for recognition and clearance of C. pneumoniae [8,9].
Pathogen recognition activates a intracellular signaling pro-
grams [5]. One of these leads to activation of the transcription
factor interferon (IFN) regulatory factor (IRF)3, which plays a
critical role in transcriptional activity of Type I IFN genes and
IFN-stimulated genes (ISG)s. IRF3 is expressed constitutively and
resides in the cytosol in a latent form [5]. When receiving the
appropriate signal, IRF-3 undergoes phosphorylation, dimeriza-
tion and nuclear translocation. TANK binding kinase (TBK) 1
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for phosphorylation of IRF3 and IRF7 [10,11]. Bacterial
pathogens replicating in the cytoplasm of the host cell (e.g. Listera
monocytogenes, Legionella pneumophilla) or releasing bacterial material
into the host cytoplasm (group B streptococcus) have recently been
reported to induce expression of IFNs and ISGs via cytoplasmic
PRRs and the TBK1/IRF-3 axis [12–14]. Thus, interaction
between bacterial and host cell cytoplasm seems to be sensed and
to trigger expression of IFNs and ISGs.
The type 3 secretion system (T3SS) is primarily characterised by
the translocation of the bacterial ‘‘effectors’’ into the eukaryotic
cell for the manifestation of pathogenesis. The T3SS is important
for many gram-negative bacterial species like Shigella, Salmonella
and Yerisinia in delivering the effector proteins into the eukaryotic
cells directly [15]. Chlamydia uses a T3SS through the
developmental cycle and may possibly employ this to translocate
the different effectors into the host cell depending on the phase of
the bacterial developmental cycle [16]. More recently, it has been
demonstrated that T3SS may also play a part in triggering the
innate immune response to infections with different bacteria
including C. pneumoniae [17,18].
While Type I IFNs and expression of ISGs has classically been
known to stimulate antiviral activity, the recent appreciation of the
IFN response in bacterial infections has led to increasing attention
on their role in the anti-bacterial defense [19–22]. Although the
IFN response plays a protective role during some bacterial
infections, studies in murine models have suggested that IFNs
play a deleterious role in defense against Chlamydia infections.
Therefore, knowledge on the mechanisms governing expression of
ISGs during infection with C. pneumoniae may provide important
evidence on the pathology of Chlamydia infections. In this work we
demonstrate that expression of ISGs during infection with C.
pneumoniae is mediated by nucleotide-sensing PRRs residing in
endosomes and the cytoplasm, and this response is induced
through signalling by TBK1/IKKe and is dependent on bacterial
replication and the bacterial type III secretion system.
Materials and Methods
Cells and infection
Murine embryonic fibroblasts (MEF) cell lines were used,
C57BL/6 and mavs
2/2 were obtained from Z.J.Chen, Depart-





2/2 were obtained from S.
Akira, Department of Host Defense, Research Institute for
Microbial Diseases, Osaka University Japan and atg +/2 and
atg52/2 cells were procured from RIKEN Bio Resource Center,
Japan. All cell types were grown in RPMI 1640 (Gibco BRL,
Grand Island, NY, USA) containing 25 mM HEPES, 15% (w/v)
FCS, 0.3%,10 mg/ml gentamicin in growth medium and genta-
micin 2 mg/ml in infection medium at 37uC in presence of 5%
CO2. Cells were infected with Chlamydia pneumoniae strain TWAR
CWL029 obtained from American Type Culture Collection
(Rockville, MD, USA) at MOI 5 by centrifugation for 30 minutes,
2400 rpm, at 35uC.
Reagents
Cycloheximide (Sigma Aldrich), a eukaryotic protein biosyn-
thesis inhibitor was used at a concentration of 1 mg/ml. The LPS/
TLR4 inhibitor Polymyxin B was purchased from Invivogen and
used at a working concentration of 50 mg/ml. The endosomal
TLR inhibitor chloroquine (used at a concentration of 10 mM) was
obtained from InvivoGen. Ampicillin was used at a concentration
of 20 mg/ml. The RNA polymerase III inhibitor ML-60218
(Calbiochem) was used at a concentration of 30 mM and the T3SS
inhibitor INP0341, a derivative of salicylidene acylhydrazine and
its analogue control INP0406, were kindly donated by Innate
Pharmaceuticals, Umea ˚, Sweden, and used at a concentration of
60 mM.
Immuno-fluorescence and Microscopy
To analyse chlamydial inclusions and development inside the
fibroblasts, cells were cultivated on glass cover slips and infected
with 5 culture forming units (IFU) per cell of C. pneumoniae were
fixed at 36 hr time post challenge. Infected cells were treated with
methanol fixed and stained with MAb 15.1 against Chlamydia LPS
([23,24]).
Real-time PCR (qRT-PCR)
ISG expression at different points in time post infection of C.
pneumoniae was quantified by quantitative real-time PCR (qRT-
PCR) analysis of the generated cDNAs. Total RNAs were then
isolated using the High Pure RNA Isolation Kit Protocol (Roche)
and subjected to RT-PCR to generate cDNA using p(dT)15
primer (Roche) and Expand Reverse Transcriptase (Roche),
allowing reverse transcription of total sample mRNA. The real
time PCR was performed using specific primers for murine ISG56
forward primer 59-ACC ATG GGA GAG AAT GCT GAT-39,
reverse primer: 59-GCC AGG AGG TTG TGC-39; murine
CCL5 forward primer 59- ACT CCC TGC TGC TTT GCC
TAC-39, reverse primer 59- GAG GTT CCT TCG AGT GAC A-
39; murine CXCL10 forward primer 59- CGA TGA CGG GCC
AGT GAG AAT G-39, reverse primer 59- TCA ACA CGT GGG
CAG GAT AGG CT-39; murine b-actin forward primer: 59- TAG
CAC CAT GAA GAT CAA GAT -39, reverse primer: 59-CCG
ATC CAC ACA GAG TAC TT -39 and quantified using
QuantiTect SYBR Green PCR Kit (Qiagen) and the cycle
number at detection threshold (crossing point (cp)) weas deter-
mined using the Lightcycler (Roche) analyzer and the LightCycler
Software 3.0.
Statistics
The data are presented as means 6 SD. The statistical
significance was estimated with the Wilcoxon rank sum test (p-
values of ,0.05 were considered to be statistically significant).
Reproducibility of data
The results shown in this work are derived from data that are
representative for the results obtained. For each series of
experiments, two to five independent repetitions were performed.
Results
Chlamydia pneumoniae induces expression of ISGs with a
delayed kinetics compared to viruses
In order to test whether C. pneumoniae establishes productive
infection in murine fibroblasts, we treated the cells with the bacteria
for 36 h and looked for intracellular vacuoles by confocal
microscopy. As shown in Fig. 1A, C. pneumoniae infection did lead
to development of small bacterial inclusions, and this was strongly
enhanced if the cells were treated with the eukaryote protein
synthesis inhibitor, cyclohexamide. This shows that the cell can
mount a defence against the infection. All the following experiments
were done without cyclohexamide treatment. To evaluate the
expression of ISGs in response to C. pneumoniae infection, we
harvested total RNAfrom cells receivingbacterial or mock infection
for the indicated time intervals and looked for expression of CCL5,
Chlamydia and IFN Expression
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infection, with a slow kinetics, where the mRNA levels did not
exceede background levels for the first 8 h post bacterial challenge
and subsequently were increasingly steady through the 36 h of the
experiment (Fig. 1B–C and data not shown). For comparison, we
examined the expression of ISG56 in response to two viruses,
namely herpes simplex virus (HSV, a DNA virus) and Sendai virus
(SeV, an RNA virus). Interestingly, while both viruses induced a
potent ISG56 response, this occurred through a rapid and transient
kinetics (Fig. 1D–E). Thus, C. pneumoniae induces expression of ISGs
with a delayed kinetics compared to viruses.
Chlamydia pneumoniae-induced expression of ISGs is
dependent on bacterial recognition by endosomal and
cytoplasmic nucleotide-sensing PRRs
Recent evidence suggests that induction of type I IFN and ISG
expression by bacteria is mediated mainly through intracellular
PRRs, with RNA and DNA constituting important PAMPs
[12,14,25–27]. To address the role of TLRs and RLRs in
stimulation of the IFN response during infection with C.




2/2 MEFs with the bacteria and measured accumulation of
ISG56 mRNA 18 h post infection. Interestingly, the ability of C.
pneumonia to trigger the IFN response was dependent on intact
pathways from both TLRs (MyD88, TRIF) and RLRs (MAVS)
(Fig. 2A and 2B). Both knock-out cells stimulated normal induction
of ISGs in response to transfected virus-derived DNA (data not
shown). For the viruses, which also induced expression of ISG56,
HSV-2 relied on both TLRs and RLRs (Fig. 2C and 2D) whereas
SeV triggered the response entirely via RLRs (Fig. 2E and 2F).
To investigate which PRRs may be involved in innate
recognition of C. pneumonia, we treated MEFs with PAMPs, known
to activate IFN-inducing TLRs and RLRs, and measured ISG56
mRNA expression. The TLR3 agonist polyIC strongly induced
ISG56 expression, and the TLR4 agonist LPS induced a modest
but significant response (Fig. 2G). Intracellular delivery of polyIC,
which activates RLRs [28], also induced ISG56 expression (data
not shown). By contrast, no induction of ISG56 was observed after
treatment with the TLR9 agonist ODN1826 or the TLR7 agonist
ssRNA40 (Fig. 2G and data not shown). TLR2, 3, 4 have been
reported to be involved in recognition of Chlamydia species
[7,29,30,30,31], and therefore we inhibited LPS/TLR4 action
using polymyxin B and also the endosomal TLRs (TLR3, 7, 8, 9)
using chloroquine. Inhibition of LPS activity did not affect the ISG
response to C. pneumoniae, but treatment of the cells with
chloroquine strongly inhinited the ability of the bacteria to induce
ISG56 expression (Fig. 2H).
Recently it has been reported that RNA polymerase III
transcribes AT-rich DNA in the cytoplasm, thus generating
RNA-species recognized by RLRs (refs). To examine if the ISG
response during C. pneumoniae infection was triggered through this
pathway, we inhibited RNA polymerase III with ML-60218
(30 mM) and infected with the bacteria. However, this treatment
did not affect C. pneumoniae-induced ISG56 expression (data not
shown), thus suggesting that MAVS signaling during C. pneumoniae
infection is not activated by RNA polymerase III driven
transcription of AT-rich regions in the bacterial genome.
Collectively, C. pneumoniae infection stimulates expression of ISGs
via recognition by endosomal TLRs and cytoplasmic RLRs.
Induction of ISGs by Chlamydia pneumoniae is
dependent on TBK1/IKKe, bacterial replication and the
type III secretion system
The observed essential role for intracellular nucleotide-sensing
PRRs for induction of ISGs by C. pneumonia prompted us to
examine the potential role for the IRF-3 kinases TBK1 and IKKe,
which are involved in signaling from most of these PRRs. As
expected activation of the ISG response during C. pneumonia
infection was dependent on these kinases (Fig. 3A).
The observed delayed kinetics of ISG expression relative to viral
infections suggested that bacterial replication was necessary for
induction of the response. To test this, we inactivated the bacteria
with UV treatment and examined for induction of ISG56. As
shown in Fig. 3B, inhibition of bacterial replication prevented
induction of ISG56 expression.
The requirement for both endosomal TLRs, cytosolic RLRs
and bacterial replication led us to hypothesize that interactions
between the bacterial vacuole and the host cytoplasm are
important for innate immune recognition and that cytoplasmic
PAMPs are delivered to endosomes through autophagy. The
potential role for autophagy was examined by comparing atg5+/2
and atg52/2 cells with respect to C. pneumoniae-induced
Figure 1. Chlamydia pneumoniae induces expression of ISGs
with a delayed kinetics compared to viruses. (A) MEF cells were
infected with C. pneumoniae (5 UFU/cell) in presence or absence of
cycloheximide (CHX, 1 mg/ml). 36 hrs post infection, the cells were fixed
and stained with an antibody against chlamydial LPS and fluorescence/
Nomaski images were obtained. (B–E) MEFs were infected with (B–C) C.
pneumonia, MOI 5(D) HSV-2, MOI 1, or (E) SeV, MOI 1 for the indicated
time intervals. Total RNA was harvested and mRNA levels of ISG56 and
CCL5 were determined by real-time PCR and normalized to b-actin. The
data are presented as means of triplicate cultures +/2 st.dev. Similar
results were obtained in 2–5 independent experiments. RU, relative
units. Infection-induced gene expression significantly above the
expression induced by mock infection at the same tine point
(p,0.05) is marked with an asterisk, *.
doi:10.1371/journal.pone.0010005.g001
Chlamydia and IFN Expression
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machinery did not impact on the IFN response evoked by C.
pneumoniae (Fig. 3C). By contrast, inhibition of the type III secretion
system using the inhibitor INP0341 largely prevented induction of
ISG56 expression whereas the control compound INP0406 had no
effect (Fig. 3D). Importantly, ampicillin, which halts the Chla-
mydia replication cycle before the conversion of RBs in to EBs but
leaves interaction with the host cytosol unaffected [29], did not
interfere with ISG56 expression. Thus, stimulation of ISG
expression by C. pneumonia is dependent on bacterial replication,
signaling through TBK1/IKKe and the T3SS.
Discussion
C. pneumoniae is an obligate intracellular gram-negative bacteria
responsible for about 10% of community-acquired pneumonias. C.
pneumoniae has a 2-stage life-cycle involving infectious EB and
metabolically active RB [3]. The host cytokine response to
Chlamydia infection is involved in both protection and pathogenesis
of the disease, with e.g. IFN-c exerting bactericidal activities and
interleukin 1 contributing to tissue damage [6]. Type I IFNs,
which were originally believed primarily to participate in the host
response to viral infections, have recently emerged as important
players in host-defense and pathogenesis of bacterial infections.
However, unlike the protective role of type I IFNs in antiviral
defense, this class of cytokines has been reported to participate in
development of disease during several bacterial infections [19–22].
For instance, type I IFNs enhance susceptibility of mice to genital
and lung infection with Chlamydia muridarum through a mechanism
involving inhibition of the CD4 T cell response and enhancement
of macrophage apoptosis [19,32]. Despite the role of type I IFN in
the pathogenesis of Chlamydia infection, it remains unresolved
which PRRs are responsible for induction of the IFN response
during infection with Chlamydia. In this work we demonstrate that
C. pneumoniae induces expression of ISGs with a delayed kinetics
relative to viruses, and that this is dependent on bacterial
replication, innate immune recognition by intracellular nucleo-
tide-sensing PRRs and signaling through TBK1/IKKe. Finally,
we report that induction of the ISG response is dependent on
bacteria-host interaction through the T3SS.
The finding that C. pneumoniae-induced expression of ISGs is
dependent on replication and occurs with a delayed kinetics relative
tovirusessuggeststhat PAMPsproduced lateduringthebacterial life
cycle (orexposed toPRRsonlyat late timepoints)are responsible for
induction of the IFN response. Since the conversion of EBs to RBs
occurs between 8 and 10 h after infection, it is tempting to speculate
that the Chlamydial ISG-inducing nucleotide PAMP is produced or
accessible only when RBs are actively dividing.
Figure 2. Chlamydia pneumoniae-induced expression of ISGs is dependent on bacterial recognition by endosomal and cytoplasmic
nucleotide-sensing PRRs. (A–F) WT, myd88
2/2 trif
2/2 and mavs
2/2 MEFs were infected with (A–B) C. pneumoniae, MOI 5, for 36 h (C–D) HSV-2,
MOI 1, 6 hrs, or (E–F) SeV, MOI 1, 6 hrs. Total RNA was harvested and levels of ISG56 mRNA were determined by real-time PCR. (G) MEFs were
stimulated with polyIC (25 mg/ml), LPS (200 ng/ml), and ODN1826 (1 mM) alone or in combination as indicated. Total RNA was harvested 6 hrs post-
stimulation, and levels of ISG56 mRNA were determined by real-time PCR. (H) The cells were infected with C. pneumonia, MOI 5, for 18 h in the
presence or absence of polymyxin B (50 mg/ml) or chloroquine (10 mM) before harvest of total mRNA. The measured ISG56 mRNA levels were
normalized to b-actin, and data are presented as means of triplicate cultures +/2 st.dev. Similar results were obtained in 2–3 independent
experiments. RU, relative units.
doi:10.1371/journal.pone.0010005.g002
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response. This is in agreement with a recent report that C. muridarum
induces expression of a subset of inflammatory cytokines in a
manner dependent on the T3SS [17]. The Salmonella enterica
Typhimurium T3SS has also been reported to stimulate innate
immune responses, but in that case it was reported to occur directly
via bacterial effector proteins independent of any known innate
immune receptors [33]. TLRs are believed to interact with the
cytoplasm through autophagy [34]. However, abrogation of
autophagy by deletion of the atg5 gene did not affect the ability of
C. pneumoniae to stimulate ISG expression, suggesting other
mechanisms to be involved. Others have reported that the TLR
adaptor MyD88 localizes to the inclusions during Chlamydia
trachomatis infections, and there may therefore be a more direct
interaction between the Chlamydia inclusion and endosomal TLRs
[29]. Therefore, based on our findings, we propose that active
secretion of specific molecules by the T3SS during the RB stage of
the bacterial life cycle either leads to exposure of PAMPs or
amplifies host cell signaling, thus augmenting the ISG response. As
to the firstpossibility,thereis nodirectevidenceof nucleotidesbeing
translocated across T3SS. However, one recent work reported that
synthetic RNA amplified the IFN-b response induced by Yersinia
pseudotuberculosis and this was dependent on the T3SS [35].
Concerning the later possibility, this would be parallel to the recent
finding that C. trachomatis infection stimulates production of reactive
oxygen species through the T3SS, which leads to activation of the
inflammasome and production of bioactive IL-1b [18].
Bacteria are recognized through all known classes of PRRs, and
specifically for Chlamydia it is known that TLR2, TLR4, NOD1,
NOD2, NLRP3 and possibly also TLR3 play a role in innate
recognition of the bacteria [8,9,18,29–31,36]. In this work we
found that endosomal TLRs (which include the nucleotide-sensing
TLR3, 7, and 9) and cytoplasmic RLRs (which include the RNA-
sensing RIG-I and MDA5) were essential for induction of the ISG
response by C. pneumonia, and that the MEFs induced ISG56
expression after stimulation with agonists for TLR3, RIG-I, and
MDA5 but not after stimulation with agonists for TLR7 and 9.
Therefore, the ISG response to C. pneumoniae is likely to be
mediated by intracellular RNA-sensing PRRs. This is in contrast
to most reports on bacterial induction of the IFN response, which
is mediated primarily by cytoplasmic DNA-sensing PRRs
[12,14,25,26]. However, one recent study demonstrated recogni-
tion of group B streptococcus in TLR7 in conventional dendritic
cells as a central mechanism of type I IFN induction [27].
Previously we found that purified DNA from different bacteria all
stimulated TLR9, but only a subset of the live bacteria stimulated
this PRR [37]. This suggests that the nature of the interactions
between host cells and the bacterial life cycle, rather than the
intrinsic immunostimulatory potential of bacterial nucleotides, are
responsible for which PRRs that mediate the innate immune
response to infection.
In conclusion, we report that activation of the type I IFN
response during C. pneumoniae infection is mediated by intracellular
nucleotide-sensing PRRs, which operate through a mechanism
dependent on the bacterial T3SS. Thus, specific strategies to
inhibit the chlamydial T3SS may be used to limit the detrimental
effects of the type I IFN system in the host response to Chlamydia
infection, and hence to limit the pathology of infections with this
intracellular bacterial pathogen.
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